Merino de Paz, N.; García-González, M.; Gómez-Bernal, F.; Quevedo-Abeledo, J.C.; de Vera-González, A.; López-Mejias, R.; Abreu-González, P.; Martín-González, C.; González-Gay, M.Á.; Ferraz-Amaro, I.
Relationship between Malondialdehyde Serum Levels and Disease Features in a Full Characterized Series of 284 Patients with Systemic Lupus Erythematosus. Antioxidants 2023, 12, 1535.
https://doi.org/10.3390/antiox12081535
AMA Style
Merino de Paz N, García-González M, Gómez-Bernal F, Quevedo-Abeledo JC, de Vera-González A, López-Mejias R, Abreu-González P, Martín-González C, González-Gay MÁ, Ferraz-Amaro I.
Relationship between Malondialdehyde Serum Levels and Disease Features in a Full Characterized Series of 284 Patients with Systemic Lupus Erythematosus. Antioxidants. 2023; 12(8):1535.
https://doi.org/10.3390/antiox12081535
Chicago/Turabian Style
Merino de Paz, Nayra, María García-González, Fuensanta Gómez-Bernal, Juan C. Quevedo-Abeledo, Antonia de Vera-González, Raquel López-Mejias, Pedro Abreu-González, Candelaria Martín-González, Miguel Á. González-Gay, and Iván Ferraz-Amaro.
2023. "Relationship between Malondialdehyde Serum Levels and Disease Features in a Full Characterized Series of 284 Patients with Systemic Lupus Erythematosus" Antioxidants 12, no. 8: 1535.
https://doi.org/10.3390/antiox12081535
APA Style
Merino de Paz, N., García-González, M., Gómez-Bernal, F., Quevedo-Abeledo, J. C., de Vera-González, A., López-Mejias, R., Abreu-González, P., Martín-González, C., González-Gay, M. Á., & Ferraz-Amaro, I.
(2023). Relationship between Malondialdehyde Serum Levels and Disease Features in a Full Characterized Series of 284 Patients with Systemic Lupus Erythematosus. Antioxidants, 12(8), 1535.
https://doi.org/10.3390/antiox12081535